TMEM16F Lipid Scrambling Regulates Ferroptosis and Tumor Imm
2026-07-08
This article reviews how TMEM16F-mediated lipid scrambling suppresses ferroptosis by remodeling plasma membrane phospholipids, and how inhibiting this process sensitizes tumor cells to ferroptotic death and enhances immune rejection. The findings reveal new mechanistic links between membrane lipid dynamics, cell death execution, and immunotherapy responsiveness.
Phosphatase Inhibitor Cocktail 1: Advancing Fidelity in Card
2026-07-08
Explore how Phosphatase Inhibitor Cocktail 1 preserves protein phosphorylation in cardiac signaling studies. This article delivers a mechanistic, application-driven perspective for researchers seeking robust, reproducible results in phosphoproteomic analysis.
Dextromethorphan Hydrobromide: Protocols for Neuroprotection
2026-07-07
Dextromethorphan hydrobromide offers precise NMDA receptor antagonism and robust neuroprotection for in vitro and in vivo models. This guide translates peer-reviewed findings into practical workflows, advanced applications, and troubleshooting strategies for reliable, reproducible results.
Selective P2X1 Receptor Inhibition Alters Platelet Activatio
2026-07-07
The reference study demonstrates that NF449 acts as a selective antagonist of the platelet P2X1 receptor, leading to significant modulation of platelet activation and thrombosis without extending bleeding time. These insights refine our understanding of purinergic signaling in platelet biology and offer new directions for targeted antithrombotic intervention.
Sulfo-Cy3 NHS Ester: Transforming Vascular Remodeling Resear
2026-07-06
This thought-leadership article explores how Sulfo-Cy3 NHS Ester—a hydrophilic, sulfonated fluorescent dye—addresses key bottlenecks in the visualization, quantification, and manipulation of protein dynamics during vascular remodeling. Integrating mechanistic insights from recent studies on collateral circulation and stemlike capillary expansion, the article provides actionable guidance for translational researchers. It also contextualizes APExBIO’s Sulfo-Cy3 NHS Ester within the competitive landscape, emphasizing its unique value for complex bioconjugation workflows in cell biology and vascular disease research.
Super-Enhancer RNA Drives Metastasis in Nasopharyngeal Carci
2026-07-06
This study elucidates how chemical carcinogens induce a specific super-enhancer RNA (seRNA-NPCm) that promotes nasopharyngeal carcinoma (NPC) metastasis via the NPM1/c-Myc/NDRG1 axis. The findings advance understanding of enhancer-mediated gene regulation in cancer and suggest new avenues for biomarker development and therapeutic targeting.
Salmonella Haem Biosynthesis Suppresses Macrophage Phagocyto
2026-07-05
This study uncovers how Salmonella Typhimurium leverages a methyltransferase-regulated haem biosynthesis pathway to inhibit macrophage phagocytosis and promote infection in mice. The findings reveal a novel immune evasion mechanism with direct implications for understanding pathogen virulence and host-pathogen interactions.
Doxycycline Hyclate: Matrix Metalloproteinases Inhibitor in
2026-07-04
Doxycycline hyclate enables precise modulation of matrix metalloproteinases, unlocking translational workflows for blood-brain barrier protection and cognitive function studies. Its validated efficacy in arsenic-induced neurotoxicity models and versatile solubility make it a cornerstone for advanced neurovascular and infectious disease research.
Hydroxychloroquine Sulfate Protocols for Autoimmune Disease
2026-07-03
Hydroxychloroquine Sulfate (SKU B4874) is designed for precise inhibition of autophagy and TLR7/9 signaling in autoimmune disease research, particularly in models of systemic lupus erythematosus and rheumatoid arthritis. It is best suited for short-term, aqueous-based workflows and should not be used in protocols requiring organic solvents or long-term solution storage.
Cyclophosphamide: Translational Leverage in Cancer and Immun
2026-07-03
This thought-leadership article explores Cyclophosphamide’s dual roles as an alkylating chemotherapeutic agent and immunosuppressant, blending mechanistic insights with strategic recommendations for translational researchers. Drawing on the latest protocols, competitive perspectives, and clinical context, the article situates Cyclophosphamide at the vanguard of precision oncology and immune modulation research, offering actionable guidance for maximizing its experimental and translational impact.
GSK3 Inhibition as a Host-Directed Approach for Tuberculosis
2026-07-02
The referenced iScience study uncovers that inhibiting glycogen synthase kinase 3 (GSK3) in human macrophages can effectively control intracellular Mycobacterium tuberculosis (Mtb) growth. This host-directed strategy offers a promising complement to conventional antibiotics, particularly for multi-drug resistant tuberculosis, by enhancing innate immune functions and potentially reducing resistance emergence.
Acetylspiramycin (Spiramycin B): Mechanistic Leverage for Tr
2026-07-02
This article offers translational researchers a deep dive into the mechanistic and strategic dimensions of Acetylspiramycin (Spiramycin B), integrating evidence on its ribosomal targeting, immune modulation, and practical guidance for antimicrobial resistance research. It contextualizes competitive landscape advances, draws on recent workflow innovations, and positions APExBIO’s Acetylspiramycin as a next-generation tool for dissecting both microbial and host responses.
Vemurafenib (PLX4032): Optimizing BRAF Inhibition in Melanom
2026-07-01
Vemurafenib (PLX4032) sets the gold standard for dissecting BRAF V600E-driven melanoma biology and resistance mechanisms. This guide translates multi-omics breakthroughs and bench-proven workflows into actionable protocols, troubleshooting, and advanced applications for cancer research teams.
Ionomycin Free Acid: Precision Calcium Ionophore in FAK Rese
2026-07-01
Ionomycin free acid empowers researchers to reliably manipulate intracellular calcium, enabling advanced study of FAK signaling and lncRNA-mediated mechanisms in triple negative breast cancer (TNBC). This article details protocol enhancements, troubleshooting strategies, and translational insights that leverage APExBIO’s high-purity calcium ionophore to optimize experimental outcomes.
Lamotrigine in CNS and Cardiac Models: Applied Research Prot
2026-06-30
Lamotrigine, a high-purity sodium channel blocker and 5-HT inhibitor, is a cornerstone for translational research in epilepsy and cardiac safety. Here, we dissect advanced experimental workflows, highlight reference-driven protocol improvements, and deliver troubleshooting strategies that maximize reproducibility and mechanistic clarity.
466 records 13/32 page Previous Next First page 上5页 1112131415 下5页 Last page